MedTrace Logo

Quadratus Lumborum Block Type 2 Versus Posterior Transversus Abdominus Plane Block

NCT04773730 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-06-06

No results posted yet for this study

Summary

This patient population are at risk of adverse effects secondary to inadequate pain management such as inadequate maternal bonding and late ambulation.

Regional analgesia is preferred due to their opioid sparing effects and reduction in related adverse effects but the analgesia from these blocks is not known which one is superior to the other in the context of cesarean section

Conditions

  • Regional Block

Interventions

PROCEDURE

Posterior transversus abdominus plane block

Twenty mL of bupivacaine 0.25% will be injected in the plane between the transverses abdominus muscle and the fascia deep to the internal oblique muscle on each side

PROCEDURE

Quadratus lumborum block type 2

Twenty mL of bupivacaine 0.25% will be injected on the posterior surface of quadrates lumborum muscle on each side

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Principal Investigators

  • Maha Ahmed Abozeid, MD · Faculty of Medicine - Mansoura University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-15
Primary Completion
2022-08-01
Completion
2023-06-03

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04773730 on ClinicalTrials.gov